美驰投行 MC 深 沪
已收盘 01-30 16:00:00 美东时间
71.67
-0.060
-0.08%
华盛通- 最 高72.93
- 今 开72.31
- 成交量 98.13万股
- 最 低 70.995
- 昨 收 71.73
- 总市值 53.17亿
- 52周最高 78.2162
- 市盈率 静 40.37
- 换手率 1.32%
- 52周最低 45.05
- 委 比 59.36%
- 总股本 7418.04万
- 历史最高 80.29
- 量 比 1.42
- 振 幅 2.70%
- 历史最低 -11.7425
- 每 手 1
- 风险率 7.81%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Makarora Completes Acquisition of Plymouth Industrial REIT for $2.1 Billion
Makarora Management LP and Ares Alternative Credit funds have completed the acquisition of Plymouth Industrial REIT, Inc. in an all-cash transaction valued at approximately $2.1 billion. Plymouth shareholders will receive $22.00 per share, and the company will no longer be listed on any public exchange. KeyBanc Capital Markets and J.P. Morgan served as financial advisors for Plymouth, while Morrison & Foerster and Alston & Bird were legal counsel...
01-27 20:33
U.S. RESEARCH ROUNDUP-CACI International, First Citizens Bancshares, Teledyne Technologies
U.S. RESEARCH ROUNDUP-CACI International, First Citizens Bancshares, Teledyne Technologies Jan 26 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CACI International, First Citizens Bancshares and Teledyne Technologies, o
01-26 15:22
Allied Gold to be Acquired by Zijin Gold International in Friendly All-Cash Offer Valued at C$5.5 Billion
Allied Gold Corporation has agreed to be acquired by Zijin Gold International Company Limited for C$44 per share in cash, valued at approximately C$5.5 billion. The offer represents a 27% premium over Allied Gold’s 30-day VWAP on the TSX. Zijin Gold, a major global mining firm, aims to expand its African presence through this transaction. The deal is subject to shareholder and regulatory approvals and is expected to close by late April 2026. Alli...
01-26 11:00
美股大行评级 | 瑞银上调美光科技目标价从300美元升至400美元；Freedom上调百度目标价从120美元升至160美元
今日重点评级关注：Needham：维持Vaxcyte"买入"评级，目标价从90美元升至110美元；Citizens: 维持LGI Homes"跑赢大市"评级，目标价从85美元升至95美元
01-08 18:33
美股大行评级 | 拼多多、小鹏获Freedom上调目标价；多家大行首予Wealthfront"超配"评级，目标价最高23美元
今日重点评级关注：HC Wainwright & Co.：维持MetaVia Inc."买入"评级，目标价从12美元升至40美元；Canaccord Genuity：维持GH Research"买入"评级，目标价从35美元升至39美元
01-07 17:25
Morgan Stanley Maintains Overweight on Moelis, Raises Price Target to $89
Morgan Stanley analyst Ryan Kenny maintains Moelis (NYSE:MC) with a Overweight and raises the price target from $86 to $89.
01-06 23:39
美股大行评级 | 德银首予Coinbase"买入"评级，目标价340美元；AERO获多家机构首予超配评级；大摩维持苹果"超配"评级，目标价升至315美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从9美元升至10美元；摩根大通：上调Recursion Pharmaceuticals评级至"超配"，目标价从10美元升至11美元
2025-12-18 10:54
美股大行评级 | 绩后分化！甲骨文遭14家大行集体下调目标价；新思科技、Planet获多家机构上调目标价！
今日重点评级关注：HC Wainwright & Co.：维持Moleculin Biotech"买入"评级，目标价从4美元升至22美元；HC Wainwright & Co.：上调Soluna Holdings评级至"买入"，目标价5美元
2025-12-12 10:24
UBS Assumes Moelis at Neutral, Announces Price Target of $70
UBS analyst Michael Brown assumes Moelis (NYSE:MC) with a Neutral rating and announces Price Target of $70.
2025-12-11 23:33
电话会总结 ｜ Moelis(MC)2025财年Q3业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Moelis业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** - 2025年第三季度调整后营收为3.76亿美元，同比增长34% - 2025年前九个月调整后营收达到10.5亿美元，同比增长37% - 营收增长主要由M&A和资本市场业务驱动，但被资本结构咨询业务下滑部分抵消 **业务结构：** - 第三季度和前九个月业务组合均为：约三分之二来自M&A业务，三分之一来自非M&A业务 **利润率表现：** - 第三季度调整后税前利润率为22.2% - 前九个月调整后税前利润率为18.2%，管理层称这是"相比去年同期的显著改
2025-10-31 12:20
